
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles by Ben Comer from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/ben-comer/author/218/</link>
        <description>Latest articles by Ben Comer from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Doctors submit cases online</title>
          <description>Alvaro Alonso, a physician at UMass Memorial Medical Center, won $2,500 for his case video, titled Brainstem Rescue.</description>
          <link>http://www.mmm-online.com/doctors-submit-cases-online/article/199743/</link>
          <pubDate>Tue, 15 Mar 2011 21:31:00 GMT</pubDate>
          <itunes:summary>Alvaro Alonso, a physician at UMass Memorial Medical Center, won $2,500 for his case video, titled Brainstem Rescue.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Intellisphere launches OncLive.com</title>
          <description>Intellisphere launched an oncology news and information site--OncLive.com--on March 15, and changed the title of its Oncology Net Guide print journal to OncLive.</description>
          <link>http://www.mmm-online.com/intellisphere-launches-onclivecom/article/199742/</link>
          <pubDate>Tue, 15 Mar 2011 21:29:00 GMT</pubDate>
          <itunes:summary>Intellisphere launched an oncology news and information site--OncLive.com--on March 15, and changed the title of its Oncology Net Guide print journal to OncLive.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Forest Labs to acquire Clinical Data, add reps for launch</title>
          <description>Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.</description>
          <link>http://www.mmm-online.com/forest-labs-to-acquire-clinical-data-add-reps-for-launch/article/199739/</link>
          <pubDate>Tue, 15 Mar 2011 21:25:00 GMT</pubDate>
          <itunes:summary>Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Savient focusing on reimbursement </title>
          <description>Savient Pharmaceuticals launched Krystexxa, an orphan drug for chronic gout, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers.</description>
          <link>http://www.mmm-online.com/savient-focusing-on-reimbursement/article/199738/</link>
          <pubDate>Tue, 15 Mar 2011 21:23:00 GMT</pubDate>
          <itunes:summary>Savient Pharmaceuticals launched Krystexxa, an orphan drug for chronic gout, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Ex-GSK marketer unveils migraine consumer site</title>
          <description>Health Union, an online health information and social media company, announced the launch of its first website --Migraine.com--intended to foster &quot;interactions about health conditions between and among patients, caregivers, professionals and providers.&quot;</description>
          <link>http://www.mmm-online.com/ex-gsk-marketer-unveils-migraine-consumer-site/article/199729/</link>
          <pubDate>Tue, 15 Mar 2011 21:06:00 GMT</pubDate>
          <itunes:summary>Health Union, an online health information and social media company, announced the launch of its first website --Migraine.com--intended to foster &quot;interactions about health conditions between and among patients, caregivers, professionals and providers.&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Roche maintained DTC spending on Boniva, while competitors cut back</title>
          <description>Sally Field&apos;s winsome smile may have helped to curb declining sales of Roche&apos;s Boniva in 2010, but it didn&apos;t carry the drug past Warner Chilcott&apos;s Actonel, despite a substantially higher DTC spend.</description>
          <link>http://www.mmm-online.com/roche-maintained-dtc-spending-on-boniva-while-competitors-cut-back/article/197507/</link>
          <pubDate>Thu, 03 Mar 2011 18:22:11 GMT</pubDate>
          <itunes:summary>Sally Field&apos;s winsome smile may have helped to curb declining sales of Roche&apos;s Boniva in 2010, but it didn&apos;t carry the drug past Warner Chilcott&apos;s Actonel, despite a substantially higher DTC spend.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Savient focuses on reimbursement for Krystexxa launch</title>
          <description>Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.</description>
          <link>http://www.mmm-online.com/savient-focuses-on-reimbursement-for-krystexxa-launch/article/197319/</link>
          <pubDate>Tue, 01 Mar 2011 18:31:09 GMT</pubDate>
          <itunes:summary>Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Ex-GSK marketer launches migraine consumer site</title>
          <description>Health Union, an online health information and social media company, announced the launch of its first website -- Migraine.com -- intended to foster &quot;interactions about health conditions between and among patients, caregivers, professionals and providers.&quot; Health Union was co-founded last August by Tim Armand, most recently an executive product director for Avandia at GlaxoSmithKline.</description>
          <link>http://www.mmm-online.com/ex-gsk-marketer-launches-migraine-consumer-site/article/197296/</link>
          <pubDate>Tue, 01 Mar 2011 15:19:23 GMT</pubDate>
          <itunes:summary>Health Union, an online health information and social media company, announced the launch of its first website -- Migraine.com -- intended to foster &quot;interactions about health conditions between and among patients, caregivers, professionals and providers.&quot; Health Union was co-founded last August by Tim Armand, most recently an executive product director for Avandia at GlaxoSmithKline.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Forest Labs to acquire Clinical Data, add reps for Viibryd launch</title>
          <description>Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a call this morning.</description>
          <link>http://www.mmm-online.com/forest-labs-to-acquire-clinical-data-add-reps-for-viibryd-launch/article/196795/</link>
          <pubDate>Tue, 22 Feb 2011 19:37:49 GMT</pubDate>
          <itunes:summary>Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a call this morning.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Allergan&apos;s Lap-Band picks up expanded indication</title>
          <description>FDA broadened the indication on Allergan&apos;s Lap-Band to include obese adults with a body mass index of 30 to 40 and at least one obesity-related comorbid condition, such as diabetes, heart disease or gallstones. The expanded indication brings an estimated 37 million Americans into eligibility for the gastric band, according to a company statement.</description>
          <link>http://www.mmm-online.com/allergans-lap-band-picks-up-expanded-indication/article/196551/</link>
          <pubDate>Thu, 17 Feb 2011 20:26:50 GMT</pubDate>
          <itunes:summary>FDA broadened the indication on Allergan&apos;s Lap-Band to include obese adults with a body mass index of 30 to 40 and at least one obesity-related comorbid condition, such as diabetes, heart disease or gallstones. The expanded indication brings an estimated 37 million Americans into eligibility for the gastric band, according to a company statement.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  